(Q54452683)

English

Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis. (English)

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

cystic fibrosis

0 references

author name string

Jewett CV

1

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Ledbetter J

2

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Lyrene RK

3

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Brasfield DM

4

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Tiller RE

5

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

language of work or name

0 references

publication date

1 April 1985

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

The Journal of Pediatrics

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

106

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

4

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

669-672

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Summary of a Workshop on Infections in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

The art and science of the use of antibiotics in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980100-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(85)80100-1

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/3845095

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54452683&oldid=1390813914"